Blog

Feb 13, 2025, 12:35

14th Biennial Childhood Leukemia and Lymphoma Symposium 2025

The 14th Biennial Childhood Leukemia and Lymphoma Symposium (CLLS 2025) will take place 10-11 May 2025 in Budapest, Hungary.

The CLLS is an important opportunity for fellows, researchers, and junior faculty to highlight novel basic and clinical information on malignant hematological malignancies.

The unique “I-BFM and CLLS atmosphere”, which has been developed in the last 40 years on the idea of building networks across borders, by being inclusive and by promoting cooperative research projects, and through establishing new friendships, will be ever-present! We very much look forward to seeing you in Budapest 2025!

This symposium has become a cornerstone for advancing knowledge and collaboration in the field of malignant hematological disorders. It is a unique opportunity for fellows, researchers, and junior faculty to share groundbreaking basic and clinical findings on acute lymphoblastic leukemia (ALL), non-Hodgkin’s lymphoma (NHL), and myeloid disorders.

This year, the 35th I-BFM Annual Meeting will follow the CLLS and be embedded within the SIOP Europe Annual Meeting, amplifying the voice of Paediatric Oncology in Europe.

Learn more about the 6th Annual Meeting of the European Society for Paediatric Oncology here.

Conference Highlights

Keynote Topics:

How molecular-genetics shaped the diagnosis and current treatment of JMML
Is intensive chemotherapy needed for cure of primary acute lymphoblastic leukemia?
Shall we sequence all patients with leukemia for known cancer predisposition genes?
How molecular-genetics complement stage of disease in stratification of pediatric NHL
CART-cell therapy lessons learned from the GoCART Real World Data of the EBMT

Oral and poster presentations on these topics:

Biology and translational research of primary and relapsed/refractory acute leukemias and non-Hodgkin lymphomas
Host Genome Variants/Predisposition in lymphoid and myeloid hematopoietic malignancies
Supportive Care in treatment of lymphoid and myeloid hematopoietic malignancies
Leukemogenesis
Therapy and outcome of acute leukemias and non-Hodgkin lymphomas
A chance to be part of the collective effort toward curing childhood leukemia and lymphoma

Registration is open for the event.

Abstract Submission deadline is March 12, 2025.

About The I-BFM Study Group

14th Biennial Childhood Leukemia and Lymphoma Symposium 2025

The I-BFM Study Group was founded in 1987 as a collaborative effort among national leukemia research groups from Austria (BFM-A), Germany (BFM-G), France/Belgium (EORTC-CLG), Italy (AIEOP), and the Netherlands (DCLSG). Originally conceived as an informal gathering, the group aimed to compare treatment approaches for childhood acute lymphoblastic leukemia (ALL) and establish standardized protocols for diagnosis and therapy.

Over time, I-BFM has evolved into a leading international consortium dedicated to improving outcomes for children with cancer. Its core mission is to advance the understanding of childhood cancer biology and apply these discoveries to develop more effective, evidence-based treatments.